Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease
Sponsor: First Affiliated Hospital of Chongqing Medical University
Summary
As a new dual receptor (PSMA and FAP) targeting PET radiotracer, 68Ga-PSFA is promising as an excellent imaging agent applicable to PSMA/FAP positive diseases. In this research, we investigate the safety, biodistribution and potential usefulness of 68Ga-PSFA positron emission tomography (PET) for the diagnosis of lesions in PSMA/FAP positive diseases.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-05-20
Completion Date
2026-12-31
Last Updated
2025-06-04
Healthy Volunteers
Yes
Conditions
Interventions
68Ga-PSFA
Each subject receives a single intravenous injection of 68Ga-PSFA.
Locations (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China